摘要 |
Disclosed are di, tri or tetra hydroxy heterocyclic compounds, such as (2S,3R,4R,5S,6R)-2-[4-chloro-3-(4-ethoxy-benzyl)-phenyl]-6-methylsulfanyl-tetrahydro-pyran-3,4,5-triol, represented by general formula (I), or pharmaceutically acceptable salts thereof. |